Sharps Technology Inc (STSS): Rentabilitas operasi

Sharps Tech (STSS) - logo korporat

Sharps Technology, Inc. (STSS) relies on a network of automated factories for the global supply of smart syringes. The business's operating margin demonstrates current efficiency trends, where -1101.50 reflects the metric's baseline. The company is scaling B2B sales of innovative systems with minimal drug waste, although the product go-to-market stage creates a dependency on new investments due to unstable cash flows.

STSS - Rasio bathi operasi Sharps Tech ing rentang 28.04.2023 - 28.05.2026

STSS (Sharps Technology Inc): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
Pambiji fundamental perusahaan:sharpstechnology.com, STSS
Barang utama Sharps Technology

Operating margin measures the share of profit from core business operations relative to total revenue, reflecting a company's ability to generate income before accounting for financial obligations and taxes. This metric assesses the quality of cost management and the resilience of the business model. For Sharps Technology, Inc. (STSS), the automation of production lines minimizes manual labor, directly impacting the business's operational efficiency. Analyzing the dynamics of this indicator reveals the real effect of robotization. A positive trend confirms the fundamental strength and scalability of the company.

Pesaing utama

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Margin dodolan operasi ICU Medical Corp (ICUI)|Rentabilitas operasi DENTSPLY SIRONA Inc. (XRAY)|Margin dodolan operasi LeMaitre LMAT|Margin operasi ATRC (atricure.com)|Margin operasi staar.com STAA|NAGE - Rentabilitas operasi|Rentabilitas kegiatan operasi ZimVie ZIMV|ANGO: Margin operasi|Cerus Corp - Tingkat bathi operasi|Margin dodolan operasi TKNO|Margin operasi monogramorthopedics.com|Margin dodolan operasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Rentabilitas dodolan miturut bathi operasi|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi